Pericapsular Exparel for Pain Relief in Bunionectomy and Related Procedures

NATerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

July 31, 2016

Conditions

BunionHallux Rigidus

Interventions

DRUG

0.5% ropivacaine

Adductor block: 10 mL of 0.5% ropivacaine; popliteal block: 30 mL of 0.5% ropivacaine

DRUG

Exparel

106 mg (8 mL, equivalent to 120 mg bupivacaine HCl)

Trial Locations (2)

Orthopedic Foot and Ankle Center, Westerville

Grant Medical Center, Columbus